癌症治疗中的小分子声敏剂:最近的进展和临床前景
Dan Li1, Yongjie Zhu1, Weiwen Yin1,2
1College of Chemistry and Environmental Engineering, Shenzhen University, Shenzhen, Guangdong 518060, China. p.zhang6@szu.edu.cn.
Chemical Society reviews
|July 7, 2025
概括
声动疗法 (SDT) 使用超声波和声敏剂治疗癌症. 本综述详细介绍了小分子声敏剂的进展,其设计和改善瘤向的临床应用.
科学领域:
- 生物医学工程 生物医学工程
- 在瘤学瘤学.
- 材料科学 材料科学 材料科学
背景情况:
- 超声波疗法 (SDT) 是一种有前途的癌症治疗方法,利用超声波和超声波敏感剂.
- 它通过利用超声波深入组织的透来克服光动力学治疗 (PDT) 的深度限制.
- 小分子声敏剂已经从早期形式显著演变.
研究的目的:
- 系统地审查SDT的小分子声敏剂的最新进展.
- 分析设计策略和各种声敏化剂类别的性能.
- 突出目前声敏剂的临床应用和局限性.
主要方法:
- 关于小分子声敏剂的文献综述.
- 分析声敏器设计原则和结构-活动关系.
- 对SDT疗效的临床前和临床数据的检查.
主要成果:
- 已经开发出多种类型的小分子声敏化剂,包括氨酸,氨酸和金属复合物.
- 这些药物与超声波协同,产生用于瘤细胞死亡的活性氧物种 (ROS).
- 在量身定制声敏剂以提高效率和准方面取得了显著进展.
结论:
- 小分子声敏剂是一个快速发展的领域,在瘤学中具有巨大的潜力.
- 对理性设计和临床翻译的进一步研究对于优化SDT至关重要.
- SDT为深层瘤治疗提供了可行的替代方案,补充了现有疗法.
更多相关视频
09:05Generation and Quantitative Analysis of Pulsed Low Frequency Ultrasound to Determine the Sonic Sensitivity of Untreated and Treated Neoplastic Cells
Published on: July 22, 2015
11.3K
09:07Sonodynamic Therapy for the Treatment of Glioblastoma Multiforme in a Mouse Model Using a Portable Benchtop Focused Ultrasound System
Published on: February 10, 2023
2.6K
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
